We report details of two liver transplant procedures in which post-reperfusion coagulopathy was reversed by administration of protamine sulphate. Both procedures were uncomplicated until about 30 min after reperfusion of the graft, when the cut surfaces began to ooze blood. Failure of coagulation was confirmed by thrombelastography and in both cases routine coagulation tests revealed a prolonged kaolin cephalin clotting time (KCT). A heparin-like effect was suspected. Protamine sulphate 50 mg was given i.v., resulting in cessation of bleeding and normalization of the thrombelastogramand KCT. (Br. J.Anaesth. 1994; 73: 840-842) 
There are many possible causes of coagulation abnormalities during liver transplantation, including reduced synthesis and clearance of factors involved in coagulation, release of thromboplastic substances, dilution of clotting factors by massive transfusion, sequestration of platelets in the new liver and fibrinolysis [1] . Recently, interest has been directed at the role of heparin: either exogenously administered to the donor during organ harvesting, or endogenously derived heparin-like substances released from the donor liver during ischaemia [1, 2] .
Coagulation function tends to deteriorate 30-40 min after reperfusion of the donor liver in some patients, causing bleeding from small vessels. This occurs unpredictably, after the major part of surgery has been completed and the wound is about to be closed. We agree with Hickman and collegues that this bleeding may be difficult to treat [3] .
It has been shown recently that heparin can be detected in vitro in blood collected in the postreperfusion stage by prolongation of the thrombin time (TT) and activated partial thromboplastin time (aPTT), which could be returned to normal by the addition of protamine [4] . Heparin was detected in the blood of all 15 recipients whose donors had been given heparin before organ harvesting, but in only one of five recipients whose donors had not been heparinized. Thus it is possible that the main source of any heparin present may be exogenous heparin administered to the donor, but some patients endogenously derived heparin may be responsible.
Heparan sulphate is a sulphated mucopolysaccharide produced in endothelial cells. It has a cofactor activity with antithrombin III in a similar fashion to heparin, and this activity is similarly abolished by protamine sulphate. Its presence in vascular endothelium suggests a role in the prevention of intravascular coagulation. Excessive production of this or similar substances have been implicated in major bleeding disorders [5] [6] [7] . Plasma concentrations of heparan sulphate are elevated in portal hypertension [8] and may be associated with upper gastrointestinal haemorrhage. This may be caused by reduced hepatic clearance in these patients.
Case reports
PATIENT NO. 1
A 39-yr-old female weighing 64 kg presented with a series of massive haematemeses, which proved to be from gastric varices, secondary to alcoholic liver disease. At this stage she was transfused a total of 34 u. of blood, and subsequently underwent a transvenous intrahepatic portosystemic shunt (TIPSS) procedure and embolization of varices. She ceased alcohol ingestion from this time. Liver function deteriorated over the following year, necessitating transplantation.
Anaesthesia was induced with fentanyl, midazolam and etomidate, and maintained with an infusion of fentanyl and isoflurane in oxygen and air. Neuromuscular block was produced with pancuronium followed by an infusion of atracurium.
Fluid therapy consisted of crystalloid in the form of 0.9 % saline solution at 500 ml h" 1 ; colloid was given as fresh frozen plasma (FFP) or packed red cells (PRC) as indicated by haemoglobin concentration. A total of 16 u. of FFP and 6 u. of PRC were given. Calcium chloride was given by infusion as required. No previously heparinized blood products were administered and no heparin was used in scavenging red cells for reinfusion.
All invasive monitoring catheters were flushed continuously with heparin-free 5 % glucose solution. Two radial arterial catheters were inserted: one was used for monitoring arterial pressure and for withdrawal of blood for arterial gas analysis, which requires heparinization of the syringe; the other was used solely for withdrawal of blood into nonheparinized syringes, to avoid contamination of sample with heparin.
Haematological and biochemical monitoring in- The donor liver was harvested in a routine manner with other organs. Heparin 20000 u. was administered to the donor immediately before hepatectomy, and the liver was preserved with University of Wisconsin solution.
The operation was uneventful. Venovenous bypass was not used. The anhepatic time was 50 min. The cold ischaemic time of the donor liver was 7 h. Reperfusion of the donor liver was accompanied by a reduction in systolic arterial pressure to 70 mm Hg for less than 5 min; there were no other significant haemodynamic aberrations.
The surgical field remained acceptably dry throughout most the operation, and the TEG showed good clot formation and clot strength, with mild fibrinolysis at the end of reperfusion. Approximately 35 min after reperfusion a sudden increase in bleeding was noted and no bleeding vessels were found. The clotting studies taken at RP+10 were not yet available. A TEG was started at this point, which showed no clot formation for at least 33 min, at which point it was terminated. On the basis of this appearance, further FFP was given and platelets were ordered (but not given). Another TEG was started, which is reproduced in Figure 1 .
At this point the laboratory clotting studies from RP+10 became available. PT and fibrinogen concentration were noted to be satisfactory and platelet count appeared to be adequate. However, KCT was prolonged at 83 s. This, together with the appearance of the previous TEG (a straight line), lead us to postulate the presence of a heparin-like effect. KCT at RP + 30 was also prolonged.
Protamine sulphate 50 mg was given by slow i.v. injection, after which a further TEG was started (Fig. 2) , exactly 10 min after the earlier TEG ( fig. 1 ) was begun. Within a few minutes the surgeons reported a marked decrease in bleeding and proceeded to close the abdomen. The TEG developed normally, showing early onset of coagulation with good clot strength. This was confirmed by a subsequent TEG. The next set of coagulation studies showed that KCT had decreased to 50 s.
PATIENT NO. 2
A 38-yr-old female weighing 55 kg with end-stage alcoholic liver disease presented for liver transplantation. She had moderate ascites, but no other disease states. Coagulation function was slightly abnormal at the beginning of the procedure and her platelet count was low at 44 x 10 9 litre" 1 (table 2) . Anaesthesia, fluid therapy, monitoring and surgery were performed in a similar manner to patient No. 1. Five units of platelets was infused at the beginning of the procedure; a total of 8 u. of PRC and 15 u. of FFP were given. The anhepatic time was 55 min and the cold ischaemia time was 13.5 h.
The operation was uneventful. There was only slight haemodynamic upset at reperfusion of the graft, requiring no specific therapy. TEG begun 10 min after reperfusion showed no evidence of coagulation for 37 min, at which point it was terminated. Standard clotting studies on a sample taken at the same time as the TEG was started showed KCT British Journal of Anaesthesia prolonged to 100 s. Coagulation function was noted to deteriorate at 30 min after reperfusion, with the start of generalized small vessel blood loss. Another blood sample was obtained for coagulation studies and a TEG, following which protamine sulphate 50 mg was given slowly i.v. This TEG developed with prolonged r and k times, compatible with the presence of a heparin-like anticoagulant. Five minutes after administration of protamine, additional coagulation studies were performed. The TEG set up at this point developed normally, and KCT had decreased to 52 s. The surgeons reported cessation of bleeding within about 5 min of protamine administration.
In addition to the standard tests of coagulation, TT and reptilase time (RT) were measured on blood samples taken after reperfusion. These results were not available until some time later. TT was prolonged immediately after reperfusion and remained prolonged until protamine was given. RT, however, remained normal, as may have been expected if the cause of the bleeding was indeed heparin. The results of all the clotting studies in this patient are shown in table 2.
The wound was closed and the patient returned to the intensive therapy unit where she made an uneventful recovery.
Discussion
The presence of heparin in these patients was not proved, as a heparin assay was not performed. However, the combination of the clinical picture (sudden onset of bleeding), TEG compatible with heparin effect and two sets of clotting studies which were largely normal except for prolongation of KCT, provide reasonable grounds for suspicion that either heparin, or a substance behaving like heparin, was present. In addition, the fact that in patient No. 2 RT did not change from its previous value, while TT was prolonged further suggests the presence of a heparin-like effect. The reversal of all of these abnormalities by protamine would appear to confirm this theory.
Previous work in vitro has demonstrated the presence of heparin or a heparinoid, with in vitro reversal of coagulopathy by protamine. There are no previous reports of in vivo use of protamine to treat coagulopathy at this stage of a liver transplant. The dose of protamine used was entirely empirical.
However, in the clinical setting of a bleeding patient, a relatively small dose was chosen, following which the result was assessed.
Heparin 20000 u. was given to each donor immediately before harvesting the liver, as is our normal practice. The possibility that heparin administered to the donor may sequestrate in the donor liver and be released in the recipient has been investigated, and while the case is not yet proved, there is evidence that this may occur. The fact that heparin-like activity has been demonstrated previously in recipients whose donors were not given heparin further suggests that an endogenous heparinoid may be released under some circumstances from the donor liver [4] . It is not currently possible to state with certainty which of these possibilities was responsible for the heparin-like effects that we observed: it is feasible that either or both are responsible.
In our two patients, where one of these scenarios seemed to be a possibility, we gave a small dose of protamine sulphate which resulted in almost immediate resolution of coagulopathy. This had clinical benefit, and supports the above hypotheses.
